Attenua
Pharmaceutical company developing antitussive (anti-cough) medications.
Launch date
Employees
Market cap
-
Enterprise valuation
$140—210m (Dealroom.co estimates May 2018.)
Mountain View California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$35.0m | Series A | ||
* | N/A | Acquisition | |
| Total Funding | $35.0m | ||
Related Content
Recent News about Attenua
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.